Tomato juice saponin, esculeoside B ameliorates mice experimental dermatitis

Jian-Rong Zhou, Jun Urata, Takuya Shiraishi, Chiaki Tanaka, Toshihiro Nohara, Kazumi Yokomizo


Background: Allergic diseases like atopic dermatitis have recently increased. A naturally occurring glycoside, Esculeoside B, has been identified as a major component in tomato juice from the can. Accordingly, the present study investigated the effects of esculeoside B on experimental dermatitis mice.

Results: Oral treatment with 10 mg/kg of esculeoside B on the experimental dermatitis mice for 4 weeks significantly decreased the skin clinical score of 2.0 compared to the control score of 5.0. Furthermore, the scratch frequency of mice treated with esculeoside B was lower compared to the control group. Overall, the administration of esculeoside B significantly inhibited T lymphocyte proliferation and demonstrated a tendency to decrease in IL-4 production. For example, the 121.2 pg/ml in the control group decreased to 96.1 pg/ml. There was also a decrease in serum IgE levels from 928.0 ng/ml in the control group to 687.8 ng/ml.

Conclusion: Our study is the first to demonstrate how tomato juice saponin or esculeoside B may ameliorate mice experimental dermatitis by the inhibition of T cell proliferation.

Keywords: tomato juice; experimental atopic dermatitis; IgE; cytokine; tomato saponin; esculeoside B

Full Text: [Abstract] [Full Article]

DOI: 10.31989/ffhd.v8i4.420


  • There are currently no refbacks.